Alkem Laboratories Ltd - 539523 - Record Date For The Purposes Of The Annual General Meeting And Payment Of Final Dividend.
The Board of Directors at its meeting held today i.e. 30th May, 2019 has fixed 20th August, 2019 as the record date for the purposes of the Annual General Meeting and payment of final dividend. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY19 and FY19 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Outcome Of The Board Meeting Held On 30Th May, 2019
The Board of Directors at its meeting held today i.e. 30th May, 2019, has, inter alia: 1. approved the Standalone and Consolidated Audited Financial Statements of the Company for the quarter and financial year ended 31st March, 2019. 2. recommended a final dividend of Rs. 8/- (Rupees Eight only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2019, for the approval of the shareholders of the Company at the ensuing Annual General Meeting Accordingly, we are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2019 and the Auditor's Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2019. The meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 2.00 p.m. Alkem Laboratories Ltd - 539523 - Board recommends Final Dividend (AGM on August 27, 2019)
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2019, inter alia, has recommended a final dividend of Rs. 8/- (Rupees Eight only) per equity share of Rs. 2/- each for the financial year ended March 31, 2019, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. Alkem Laboratories Ltd - 539523 - Outcome of Board Meeting
Kindly refer to our intimation letter dated 21st May, 2019, pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), regarding holding of Board Meeting on 30th May, 2019 to inter alia approve the Audited Financial Results for the quarter and financial year ended 31st March 2019 and to recommend dividend, if any. Accordingly, we are enclosing herewith Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2019 and the Auditor's Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2019. The meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 2.00 p.m. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY19 and FY19 financial results will be held on Thursday, 30th May, 2019 at 5.30 P.M. Please find attached herewith the conference call details. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Audited Results And Final Dividend
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2019; and (ii) to consider and recommend Final Dividend, if any, for the Financial Year ended 31st March, 2019. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform you that US FDA had conducted an inspection at the Company's manufacturing facility located at Baddi, India from 13th May, 2019 to 17th May, 2019. At the end of the inspection, the Company has received a Form 483 with four (4) observations. The Company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA observations and the same is proposed to be filed within the timeline stipulated by US FDA. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In furtherance to our intimation dated 8th February, 2019, this is to inform you that the Company is in the process of conducting postal ballot (including voting by electronic means) for seeking approval of members of the Company for businesses as specified in the Postal Ballot Notice dated 8th February, 2019. In terms of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Postal Ballot Notice dated 8th February, 2019 along with the Postal Ballot Form. In this connection, please note that the voting would commence on Friday, 17th May, 2019 at 9.00 am and shall remain open for a period of 30 days i.e. till Saturday, 15th June, 2019 at 5.00 pm. CS Manish L. Ghia, Partner, M/s Manish Ghia & Associates, Company Secretaries, Mumbai has been appointed as Scrutinizer for conducting Postal Ballot process in fair and transparent manner. Kindly take note of the same.